Groups | G1 | G2 | G3 | G4 | G5 |
---|---|---|---|---|---|
Control | Ch | S + Ch | VAC + Ch | VAC + S + Ch | |
Initial BW (g) (49 days old) | 198.0 ± 1.9a | 201.6 ± 4.6a | 199.7 ± 7.5a | 199.8 ± 3.2a | 205.1 ± 5.9a |
Final BW (g) (5 weeks PV) | 221.9 ± 3.8c | 212.3 ± 3.2d | 236.4 ± 7.5b | 221.5 ± 4.1c | 245.2 ± 2.3a |
BWG (g) | 23.9 ± 0.26c | 10.7 ± 0.38d | 36.7 ± 0.29b | 21.7 ± 0.12c | 40.1 ± 0.35a |
Median clinical signs scores (CSS)adays PC | |||||
 2nd | 0.0 ± 0.0e | 0.35 ± 0.21a | 0.22 ± 0.17b | 0.15 ± 0.21c | 0.07 ± 0.01d |
 5th | 0.0 ± 0.0e | 0.42 ± 0.21a | 0.32 ± 0.07b | 0.26 ± 0.16c | 0.09 ± 0.02d |
 9th | 0.0 ± 0.0c | 0.23 ± 0.81a | 0.15 ± 0.02b | 0.12 ± 0.21b | 0.0 ± 0.0c |
 14th | 0.0 ± 0.0c | 0.07 ± 0.01a | 0.03 ± 0.01b | 0.02 ± 0.01b | 0.0 ± 0.0c |
HI (Log2) titers | |||||
 Weeks PV | |||||
  0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
  1st | 0.0 ± 0.0c | 0.0 ± 0.0c | 0.0 ± 0.0c | 2.8 ± 0.5b | 4.2 ± 0.7a |
  2nd | 0.0 ± 0.0c | 0.0 ± 0.0c | 0.0 ± 0.0c | 3.6 ± 1.4b | 5.6 ± 0.5a |
  3rd | 0.0 ± 0.0c | 0.0 ± 0.0c | 0.0 ± 0.0c | 4.3 ± 1.8b | 6.3 ± 0.9a |
 Weeks PC | |||||
  1st | 0.0 ± 0.0e | 2.6 ± 0.1d | 3.5 ± 0.4c | 4.6 ± 0.4b | 6.6 ± 1.2a |
  2nd | 0.0 ± 0.0e | 2.9 ± 0.4d | 4.1 ± 0.2c | 5.3 ± 0.6b | 7.1 ± 0.3a |
Mortality % PC with H9N2 | 0/30 (0)d | 3/30 (10)a | 2/30 (6.7)b | 1/30 (3.3)c | 0/30 (0)d |